Fresenius Pushes Kabi Even Higher As Former Sandoz Exec Named CEO
Kabi Scours For Divestments, ‘Business Not Understood Or Appreciated’
The Fresenius group spoke at length about its core Fresenius Kabi business during the company’s year-end financial call, not least its under pressure IV drugs in the US.
